Britta DeVore is a Senior Author for Collider who has been known to dabble with Reality News as well. When she isn't sitting behind her laptop bringing readers her hot takes on upcoming projects or ...

Shares of Replimune Group, Inc. (NASDAQ:REPL) are rising Monday after the clinical stage biotechnology company shared an important regulatory update. What To Know: Replimune said the U.S. Food and ...

If you are following Replimune Group (REPL) right now, you’re not alone. The company’s recent announcement about completing a Type A meeting with the FDA on its lead drug candidate, RP1, has put it ...

We recently published 10 Stocks Losing Big Amid Market Boom. Replimune Group, Inc. (NASDAQ:REPL) is one of the worst performers on Thursday. Replimune extended losses to a second consecutive day on ...

The fate of a once-promising cancer treatment now looks uncertain at best. The meeting was conducted with U.S. Food and Drug Administration (FDA) officials, and it took place on Tuesday. The subject ...

Though it's been over 27 years since the movie Titanic came out, for one woman, it feels like yesterday. Sarah Boll loves Titanic, telling PEOPLE she's seen the film "over 500 times," having initially ...

REPL investors may also contact Joseph E. Levi, Esq. via email at [email protected] or by telephone at (212) 363-7500. CASE DETAILS: The filed complaint alleges that defendants made false ...

U.S. Rep. Chip Roy, R-Texas, announced Thursday that he is running to become the next Texas Attorney General. Roy, who represents Texas' 21st Congressional District in the U.S. House, made the ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations for ...